Literature DB >> 22848277

RNAi targeting of hTERT gene expression induces apoptosis and inhibits the proliferation of lung cancer cells.

Linhu Ge1, Wenlong Shao, Yangde Zhang, Yuan Qiu, Dong Cui, Donghai Huang, Zhansheng Deng.   

Abstract

The present study aimed to investigate the effects of RNAi-mediated reduction in human telomerase reverse transcriptase (hTERT) expression on apoptosis and lung cancer cell proliferation. A number of cell lines, including 95D, were used. hTERT mRNA levels were detected, and the RNA concentration was calculated. MTT assay was used to detect the inhibition of cell proliferation. The siRNA with the highest suppression rate, siRNA-1, was transfected into 95D cells at three different concentrations (50, 80 and 100 nmol/l). The levels of hTERT mRNA in cells transfected with 50 nmol/l siRNA-1 were not significantly different from those of the negative control-transfected cells (P>0.05), whereas both 80 and 100 nmol/l siRNA-1 showed significant reductions in hTERT mRNA compared to the negative control cells (P<0.01). hTERT levels in the 80- and 100-nmol/l groups were not significantly different (P>0.05). Compared with the control cells, cells transfected with 50, 80 or 100 nmol/l siRNA-1 showed higher fractions of apoptotic cells 48 h post-transfection (P<0.01), although the apoptotic fraction in cells transfected with 50 nmol/l siRNA-1 was not significantly different compared to that in cells transfected with negative control siRNAs (P>0.05). Moreover, the 80- and 100-nmol/l-transfected cells showed significantly increased apoptotic indices (P<0.01). MTT results indicated a time-dependent inhibition of siRNA-1- transfected cell proliferation starting at 12 h and lasting through 48 h post-transfection; the inhibition was attenuated by 72 h post-transfection. The high levels of hTERT mRNA in all human lung cancer cell lines tested suggest that telomerase plays a role in lung carcinogenesis, and this hypothesis was strengthened by the data showing that the siRNA-mediated reduction in hTERT mRNA caused apoptosis and an inhibition of the proliferation of lung cancer cells.

Entities:  

Year:  2011        PMID: 22848277      PMCID: PMC3406510          DOI: 10.3892/ol.2011.388

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  23 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Rational siRNA design for RNA interference.

Authors:  Angela Reynolds; Devin Leake; Queta Boese; Stephen Scaringe; William S Marshall; Anastasia Khvorova
Journal:  Nat Biotechnol       Date:  2004-02-01       Impact factor: 54.908

3.  Suppression of RNA interference by adenovirus virus-associated RNA.

Authors:  M Gunnar Andersson; P C Joost Haasnoot; Ning Xu; Saideh Berenjian; Ben Berkhout; Göran Akusjärvi
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Reverse transfection on cell arrays for high content screening microscopy.

Authors:  Holger Erfle; Beate Neumann; Urban Liebel; Phill Rogers; Michael Held; Thomas Walter; Jan Ellenberg; Rainer Pepperkok
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

5.  Effects of antidiabetic drug metformin on the migration and invasion abilities of human pulmonary adenocarcinoma A549 cell line in vitro.

Authors:  Ning Wu; Hong-Jun Gu; Qiang Li
Journal:  J Thorac Dis       Date:  2010-06       Impact factor: 2.895

Review 6.  Telomerase in the human organism.

Authors:  Kathleen Collins; James R Mitchell
Journal:  Oncogene       Date:  2002-01-21       Impact factor: 9.867

7.  Telomerase activity in small-cell and non-small-cell lung cancers.

Authors:  K Hiyama; E Hiyama; S Ishioka; M Yamakido; K Inai; A F Gazdar; M A Piatyszek; J W Shay
Journal:  J Natl Cancer Inst       Date:  1995-06-21       Impact factor: 13.506

8.  Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma.

Authors:  J T Schleusener; H D Tazelaar; S H Jung; S S Cha; P J Cera; J L Myers; E T Creagan; R M Goldberg; R F Marschke
Journal:  Cancer       Date:  1996-04-01       Impact factor: 6.860

9.  Differential expression of telomerase activity in neuroendocrine lung tumours: correlation with gene product immunophenotyping.

Authors:  Nadia Zaffaroni; Daniela De Polo; Raffaella Villa; Chiara Della Porta; Paola Collini; Alessandra Fabbri; Silvana Pilotti; Maria Grazia Daidone
Journal:  J Pathol       Date:  2003-09       Impact factor: 7.996

10.  Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential.

Authors:  Masood A Shammas; Hemanta Koley; Ramesh B Batchu; Robert C Bertheau; Alexei Protopopov; Nikhil C Munshi; Raj K Goyal
Journal:  Mol Cancer       Date:  2005-07-15       Impact factor: 27.401

View more
  6 in total

1.  Effect of targeted silencing of hTERT mRNA by lentivirus-mediated siRNA on A549 lung cancer cells in vitro.

Authors:  Haibo Tang; Linhu Ge; Wenlong Shao; Yuan Qiu; Dong Cui
Journal:  Mol Biol Rep       Date:  2012-10-09       Impact factor: 2.316

2.  Nuclear condensation and cell cycle arrest induced by telomerase siRNA in neuroblastoma cells.

Authors:  Ming-Dar Tsai; Pei-Rong Chen; Lu-Tai Tien; Yu-Jyun Cai; Yih-Jing Lee
Journal:  J Neurooncol       Date:  2012-12-14       Impact factor: 4.130

3.  Sequential hTERT knockdown and apigenin treatment inhibited invasion and proliferation and induced apoptosis in human malignant neuroblastoma SK-N-DZ and SK-N-BE2 cells.

Authors:  Mrinmay Chakrabarti; Naren L Banik; Swapan K Ray
Journal:  J Mol Neurosci       Date:  2013-02-17       Impact factor: 3.444

4.  RNA interference mediated downregulation of human telomerase reverse transcriptase (hTERT) in LN18 cells.

Authors:  Ch Lavanya; M K Sibin; M M Srinivas Bharath; M Jeru Manoj; Manjunatha M Venkataswamy; Dhananjaya I Bhat; K V L Narasinga Rao; G K Chetan
Journal:  Cytotechnology       Date:  2016-10-18       Impact factor: 2.058

5.  hTERT gene knockdown enhances response to radio- and chemotherapy in head and neck cancer cell lines through a DNA damage pathway modification.

Authors:  Wojciech Barczak; Agnieszka Sobecka; Pawel Golusinski; Michal M Masternak; Blazej Rubis; Wiktoria M Suchorska; Wojciech Golusinski
Journal:  Sci Rep       Date:  2018-04-13       Impact factor: 4.379

6.  Silencing of the hTERT gene by shRNA inhibits colon cancer SW480 cell growth in vitro and in vivo.

Authors:  Ai-Qun Liu; Lian-Ying Ge; Xiao-Ling Lu; Xiao-Ling Luo; Yan-Ling Cai; Xing-Qing Ye; Fang-Fang Geng
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.